Health Economics, Policy and Law

2006 - 2025

From Cambridge University Press
Cambridge University Press, UPH, Shaftesbury Road, Cambridge CB2 8BS UK.
Bibliographic data for series maintained by Kirk Stebbing ().

Access Statistics for this journal.
Is something missing from the series or not right? See the RePEc data check for the archive and series.

Volume 16, issue 4, 2021

Why we need to face up to the ageing population? pp. 379-382

Anna Dixon

Learning from health system reform trajectories in seven Canadian provinces pp. 383-399

Susan Usher, Jean-Louis Denis, Johanne Préval, Ross Baker, Samia Chreim, Sara Kreindler, Mylaine Breton and Élizabeth Côté-Boileau

Evolution of the determinants of unmet health care needs in a universal health care system: Canada, 2001–2014 pp. 400-423

Ian Allan and Mehdi Ammi

(Re)defining legitimacy in Canadian drug assessment policy? Comparing ideas over time pp. 424-439

Katherine Boothe

Broadening the application of health technology assessment in the Netherlands: a worthwhile destination but not an easy ride? pp. 440-456

Joost J. Enzing, Saskia Knies, Bert Boer and Werner Brouwer

Necessity under construction – societal weighing rationality in the appraisal of health care technologies pp. 457-472

Tineke Kleinhout-Vliek, Antoinette de Bont and Bert Boer

Internal barriers to efficiency: why disinvestments are so difficult. Identifying and addressing internal barriers to disinvestment of health technologies pp. 473-488

Bjørn Hofmann

Organising Research and Development for evidence-informed health care: some universal characteristics and a case study from the UK pp. 489-504

Anthony Culyer and Kalipso Chalkidou

Exorcising the positivist ghost in the priority-setting machine: NICE and the demise of the ‘social value judgement’ pp. 505-511

Victoria Charlton and Albert Weale

Volume 16, issue 3, 2021

Trump v. The ACA pp. 251-255

Michael K. Gusmano, Michael S. Sparer and Lawrence D. Brown

Challenges to sovereign ambitions: forces of convergence and divergence within the global pharmaceutical sector and the UK's withdrawal from the European Union pp. 256-272

John S. F. Wright and Dimitrios Doukas

Cooperation amongst insurers on enhancing quality of care: precondition or substitute for competition? pp. 273-289

Karel C. F. Stolper, Lieke H.H.M. Boonen, Frederik T. Schut and Marco Varkevisser

Assessing the potential impact on health of the UK's future relationship agreement with the EU: analysis of the negotiating positions pp. 290-307

Nick Fahy, Tamara Hervey, Mark Dayan, Mark Flear, Mike Galsworthy, Scott Greer, Holly Jarman and Martin McKee

Tort reform: do details matter? pp. 308-324

Rachel G. Childers

The constitutional economics of the World Health Organization pp. 325-339

Eric C. Ip

Explaining system-level change in welfare governance: the role of policy indeterminacy and concatenations of social mechanisms pp. 340-354

Edoardo Ongaro and Francesco Longo

Mandatory reporting legislation in Canada: improving systems for patient safety? pp. 355-370

C. Milligan, S. Allin, M. Farr, E. Farmanova, A. Peckham, J. Byrd, R. Misfeldt, G. R. Baker and G. P. Marchildon

Expanding health care coverage in Canada: a dramatic shift in the debate pp. 371-377

Gregory P. Marchildon and Carolyn H. Tuohy

Volume 16, issue 2, 2021

The ‘Netflix plus model’: can subscription financing improve access to medicines in low- and middle-income countries? pp. 113-123

Avi Cherla, Natasha Howard and Elias Mossialos

Regulating private medical institutions: a case study of China pp. 124-137

Ziyu Liu

Exploring differences between private and public prices in the English care homes market pp. 138-153

Stephen Allan, Katerina Gousia and Julien Forder

Physicians' attitudes towards accelerated access to medicines pp. 154-169

Jessica Pace, Ian Kerridge, Sallie Pearson and Wendy Lipworth

Double-edged sword of federalism: variation in essential health benefits for mental health and substance use disorder coverage in states pp. 170-182

Charley E. Willison, Phillip M. Singer and Kyle L. Grazier

Explaining health system responses to public reporting of cardiac surgery mortality in England and the USA pp. 183-200

Mark Exworthy, Jon Gabe, Ian Rees Jones and Glenn Smith

State strategies to address medicaid prescription spending: negotiated pricing vs price transparency pp. 201-215

Shihyun Noh, Christian L. Janousek and Ji Hyung Park

Preserving social equity in marketized primary care: strategies in Sweden pp. 216-231

Ulrika Winblad, David Isaksson and Paula Blomqvist

Changes in the balance between formal and informal care supply in England between 2001 and 2011: evidence from census data pp. 232-249

Valentina Zigante, Jose Luis Fernandez and Fernanda Mazzotta

Volume 16, issue 1, 2021

Reinterpreting the health in all policies obligation in Article 168 TFEU: the first step towards making enforcement a realistic prospect pp. 8-22

Oliver Bartlett and Anja Naumann

A tribute to the foot soldiers: European health agencies in the fight against antimicrobial resistance pp. 23-37

Thibaud Deruelle

EU mental health governance and citizen participation: a global governmentality perspective pp. 38-50

Kristin Edquist

Neither protective nor harmonized: the crossborder regulation of medical devices in the EU pp. 51-63

Holly Jarman, Sarah Rozenblum and Tiffany J. Huang

Excessive pricing in the pharmaceutical industry: adding another string to the bow of EU competition law pp. 64-75

Diletta Danieli

The role of EU competition law in health care and the ‘undertaking’ concept pp. 76-89

Johan W. van de Gronden and Mary Guy

Health, federalism and the European Union: lessons from comparative federalism about the European Union pp. 90-103

Scott L. Greer

Transforming health care: the policy and politics of service reconfiguration in the UK's four health systems – CORRIGENDUM pp. 111-111

Ellen Stewart, Scott L. Greer, Angelo Ercia and Peter D. Donnelly

Volume 15, issue 4, 2020

Health care and the future of economic growth: exploring alternative perspectives pp. 419-439

Martin Hensher, John Tisdell, Ben Canny and Craig Zimitat

Re-thinking unmet need for health care: introducing a dynamic perspective pp. 440-457

Samantha Smith and Sheelah Connolly

An analysis of the development assistance for health (DAH) allocations for STD control in Africa pp. 458-476

Fumitaka Furuoka, Mohammad Zahirul Hoque, Ray Jacob and Patrick Ziegenhain

HPV vaccine status and sexual behavior among young sexually-active women in the US: evidence from the National Health and Nutrition Examination Survey, 2007–2014 pp. 477-495

Andrew J. Leidner, Harrell W. Chesson and Makram Talih

Shifting threats and rhetoric: how Republican governors framed Medicaid expansion pp. 496-508

Phillip M. Singer and Michael Rozier

The resolution process and the timing of settlement of medical malpractice claims pp. 509-529

Samantha Bielen, Peter Grajzl and Wim Marneffe

Volume 15, issue 3, 2020

Transforming health care: the policy and politics of service reconfiguration in the UK's four health systems pp. 289-307

Ellen Stewart, Scott L. Greer, Angelo Ercia and Peter D. Donnelly

The regulation of competition and procurement in the National Health Service 2015–2018: enduring hierarchical control and the limits of juridification pp. 308-324

Dorota Osipovič, Pauline Allen, Marie Sanderson, Valerie Moran and Kath Checkland

Getting involved: the extent and impact of patient and public involvement in the Swedish health system pp. 325-340

Mio Fredriksson and Jonathan Tritter

Does managed competition constrain hospitals' contract prices? Evidence from the Netherlands pp. 341-354

Rudy Douven, Monique Burger and Frederik Schut

The reimbursement of new medical technologies in German inpatient care: What factors explain which hospitals receive innovation payments? pp. 355-369

Patricia Ex, Verena Vogt, Reinhard Busse and Cornelia Henschke

Paradigms in operation: explaining pharmaceutical benefit assessment outcomes in England and Germany pp. 370-385

Katharina Kieslich

Why do health technology assessment drug reimbursement recommendations differ between countries? A parallel convergent mixed methods study pp. 386-402

Elena Nicod, Laia Maynou, Erica Visintin and John Cairns

Quality improvement in hospitals in the Russian Federation, 2000–2016: a systematic review pp. 403-413

Vasiliy V. Vlassov, Katie Bates and Martin McKee

Response to Rudolf Klein pp. 414-415

Carolyn Hughes Tuohy

The regulation of competition and procurement in the National Health Service 2015–2018: enduring hierarchical control and the limits of juridification – ADDENDUM pp. 416-416

Dorota Osipovič, Pauline Allen, Marie Sanderson, Valerie Moran and Kath Checkland

Quality improvement in hospitals in the Russian Federation, 2000–2016: a systematic review – ADDENDUM pp. 417-417

Vasiliy V. Vlassov, Katie Bates and Martin McKee

Volume 15, issue 2, 2020

The implementation of European Union (EU) rules on cross-border care: moving towards convergence? pp. 141-159

Zuzana Nordeng and Frode Veggeland

Integration vs separation in the provision of health care: 24 OECD countries compared pp. 160-172

Federico Toth

Coverage mandates and market dynamics: employer, insurer and patient responses to parity laws pp. 173-195

Robert A. Nathenson

Opening the black box of diagnosis-related groups (DRGs): unpacking the technical remuneration structure of the Dutch DRG system pp. 196-209

Sam van Herwaarden, Iris Wallenburg, Joris Messelink and Roland Bal

When do people choose to be informed? Predictors of information-seeking in the choice of primary care provider in Sweden pp. 210-224

Caroline Hoffstedt, Magnus Fredriksson, Håkan Lenhoff and Ulrika Winblad

Who knows best? Older people’s and practitioner contributions to understanding and preventing avoidable hospital admissions pp. 225-246

Jon Glasby, Rosemary Littlechild, Nick Le Mesurier and Rachel Thwaites

Should performance-based incentives be used to motivate health care providers? Views of health sector managers in Cambodia, China and Pakistan pp. 247-260

Mishal Khan, Imara Roychowdhury, Ankita Meghani, Farah Hashmani, Josephine Borghi and Marco Liverani

Political party ambitions and type-2 diabetes policy in Brazil and Mexico pp. 261-276

Eduardo J. Gómez

Addressing perceived economic obstacles to genetic testing as a way to mitigate disparities in family health history for adoptees pp. 277-287

Thomas May and James P. Evans

Volume 15, issue 1, 2020

The National Health Service (NHS) in ‘crisis’: the role played by a shift from horizontal to vertical principles of equity pp. 1-17

Sheena Asthana and Alex Gibson

Fairness in drug prices: do economists think differently from the public? pp. 18-29

Antonio J. Trujillo, Taruja Karmarkar, Caleb Alexander, William Padula, Jeremy Greene and Gerard Anderson

Access to treatment and the constitutional right to health in Germany: a triumph of hope over evidence? pp. 30-42

Stefanie Ettelt

Access to health care in post-apartheid South Africa: availability, affordability, acceptability pp. 43-55

Ronelle Burger and Carmen Christian

Is universal and uniform health insurance better for China? Evidence from the perspective of supply-induced demand pp. 56-71

Jianxing Yu, Yue Qiu and Ziying He

Willingness to pay for improved public health care services in Saudi Arabia: a contingent valuation study among heads of Saudi households pp. 72-93

Mohammed K. Al-Hanawi, Omar Alsharqi and Kirit Vaidya

Value-based provider payment: towards a theoretically preferred design pp. 94-112

Daniëlle Cattel, Frank Eijkenaar and Frederik T. Schut

Attitudes of health professionals concerning bedside rationing criteria: a survey from Portugal pp. 113-127

Micaela Pinho and Pedro Veiga

Health economics methods for public health resource allocation: a qualitative interview study of decision makers from an English local authority pp. 128-140

Emma Frew and Katie Breheny